Journey Medical (DERM) Other Non Operating Income (2021 - 2026)

Journey Medical (DERM) has reported Other Non Operating Income for 6 consecutive years, with -$1000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non Operating Income rose 98.36% year-over-year to -$1000.0; the trailing twelve-month figure through Jun 2026 stood at -$26000.0 (down 102.46% YoY), and the FY2025 full-year result was -$90000.0, down 108.0% from the prior year.
• Other Non Operating Income climbed to -$1000.0 in Q2 2026 per DERM's latest filing, from -$3000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $1.1 million in Q3 2024 and bottomed at -$101000.0 in Q3 2023.
• Historically, Other Non Operating Income has averaged $47066.7 across 5 years, with a median of -$21000.0 in 2024.
• The sharpest annual moves came in 2022 and 2024: Other Non Operating Income plunged 1000.0% in 2022, then soared 1213.86% in 2024.
• Over 5 years, Other Non Operating Income stood at -$67000.0 in 2022, then surged by 97.01% to -$2000.0 in 2023, then soared by 56350.0% to $1.1 million in 2024, then slumped by 101.69% to -$19000.0 in 2025, then surged by 94.74% to -$1000.0 in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$1000.0, -$3000.0, and -$19000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.